Find the right fit for you - faster
Get tailored insights about working at Nalpropion in one quick step.
Nalpropion Snapshot
Nalpropion Pharmaceuticals, Inc. is a patient-focused biopharmaceutical company focused on the treatment of weight loss.
Nalpropion was formed on April 17, 2018 as a joint venture among Pernix Therapeutics Holdings, Inc., Highbridge Capital Management, LLC and Whitebox Advisors LLC. Nalpropion was established for the purposes of purchasing substantially all commercial assets of Orexigen.
Our team is creative, passionate, collaborative and determined to succeed. Nalpropion offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
Nalpropion was formed on April 17, 2018 as a joint venture among Pernix Therapeutics Holdings, Inc., Highbridge Capital Management, LLC and Whitebox Advisors LLC. Nalpropion was established for the purposes of purchasing substantially all commercial assets of Orexigen.
Our team is creative, passionate, collaborative and determined to succeed. Nalpropion offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
